FIRST EXTENSION - GRANTED
granted
on 27 Dec 2024
Last Applicant/ Owned by
1055 Westlakes Drive, Suite 300
Berwyn
PA
19312
Serial Number
98164969 filed on 05th Sep 2023
Registration Number
N/A
Correspondent Address
Patrick J Halloran
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
NOBRXIOL
Pharmaceutical substances for the treatment of epilepsy, convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus pharmaceutical preparations and substances for the treatment of pediatric epilepsy
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical substances for the treatment of epilepsy, convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus pharmaceutical preparations and substances for the treatment of pediatric epilepsy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98164969
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 27th Dec 2024 | SOU EXTENSION 1 FILED |
| 27th Dec 2024 | SOU EXTENSION 1 GRANTED |
| 27th Dec 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 27th Dec 2024 | SOU TEAS EXTENSION RECEIVED |
| 30th Jul 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 04th Jun 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 04th Jun 2024 | PUBLISHED FOR OPPOSITION |
| 15th May 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 01st May 2024 | ASSIGNED TO EXAMINER |
| 01st May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |